Deguelin induces the apoptosis of lung cancer cells through regulating a ROS driven Akt pathway
Open Access
- 25 February 2015
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 15 (1) , 25
Abstract
Duguelin is a rotenoid extracted from plants and has potent antitumor effects in vitro and in vivo. However, the mechanism underlying the antitumor effect remains unclear. Our preliminary study showed that Deguelin is effective to stimulate the generation of Reactive Oxygen Species (ROS). In the current study, we evaluated the in vitro cytotoxicity of Deguelin against lung cancer cells and studied whether a ROS scavenger, N-acetyl-cysteine (NAC), can reverse the inhibitory effect of Deguelin. We showed that the dose-dependent apoptotic inducing effect of Deguelin could be partially reversed by the co-administration of NAC. Moreover, Deguelin reduced the phosphorylation of Akt protein and induced the apoptotic protein Caspase-3 in a dose-dependent manner. Co-treatment with NAC partially attenuated this effect and rescued some cells from apoptosis. Deguelin induces the apoptosis of cancer cells through a ROS driven Akt pathway, which could translate into a promising therapeutic for lung cancer.Keywords
This publication has 48 references indexed in Scilit:
- An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasionInternational Journal of Nanomedicine, 2013
- Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative Breast Cancer CellsPLOS ONE, 2013
- Enhanced in vitro and in vivo therapeutic efficacy of codrug-loaded nanoparticles against liver cancerInternational Journal of Nanomedicine, 2012
- TRESK gene recombinant adenovirus vector inhibits capsaicin-mediated substance P release from cultured rat dorsal root ganglion neuronsMolecular Medicine Reports, 2012
- Resveratrol Suppresses Constitutive Activation of AKT via Generation of ROS and Induces Apoptosis in Diffuse Large B Cell Lymphoma Cell LinesPLOS ONE, 2011
- Selective killing of cancer cells by a small molecule targeting the stress response to ROSNature, 2011
- ROS‐mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3−/− miceThe EMBO Journal, 2010
- Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapyAdvances in Enzyme Regulation, 2008
- Down-Regulation of Inhibitor of Apoptosis Proteins by Deguelin Selectively Induces Apoptosis in Breast Cancer CellsMolecular Pharmacology, 2007
- ROS stress in cancer cells and therapeutic implicationsDrug Resistance Updates, 2004